Based on years of research and trials at major medical institutions, Rebion is commercializing the breakthrough Neural Performance Scanning (NPS) to identify and help manage life-altering diseases that manifest from functional impairments in the brain; including traumatic brain injury (TBI) and amblyopia (lazy eye). NPS portable point-of-care devices provide previously unavailable information for fast and impactful triage, making early disease detection, intervention and customized treatment more accessible.